stockrow
Friday 6 November 2026
Export ACON’s income statement to Excel — free account
Aclarion, Inc.
ACON Healthcare Health Information Services
Aclarion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75,700.00, up 65.6% from fiscal 2024.
- Revenue
- +78.5%
- EPS
- +67.9%
- Free cash flow
- −74.2%
Quarter to September 2026, against a year earlier
1.66
0.10
+6.41%
Follow ACON
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
67.96 | 84.72 | 89.52 | 32.33 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(3.32) | (2.67) | (2.64) | (1.50) | |
P/B ratio |
0.45 | 0.42 | 0.35 | 0.19 | |
Price to Tangible BV |
0.49 | 0.45 | 0.38 | 0.21 | |
EV/Sales |
(73.77) | (107.19) | (151.91) | (123.47) | |
EV/EBITDA |
0.77 | 0.95 | 1.42 | 1.37 | |
EV/Operating CF |
0.81 | 1.11 | 1.62 | 1.30 | |
EV/FCF |
0.79 | 1.09 | 1.58 | 1.27 | |
Quick Ratio |
13.84 | 15.76 | 19.34 | 14.42 | |
Current Ratio |
14.17 | 16.20 | 19.65 | 14.81 | |
Net Debt/EBITDA |
0.00 | 5.75 | 6.50 | 6.23 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.01 | 0.01 | 0.00 | 0.01 | |
Operating CF/Net income |
0.77 | 0.97 | 0.93 | 0.86 | |
Capex/Depreciation |
0.00 | (0.70) | (0.81) | (0.68) | |
Research and Development Expense of Revenue |
1,101.33% | 1,178.97% | 1,494.79% | 1,422.16% | |
Selling, General and Administrative Expense of Revenue |
7,107.24% | 10,360.71% | 12,679.15% | 9,360.54% | |
Intangible Assets out of Total Assets |
0.08 | 0.07 | 0.06 | 0.09 | |
Share Based Compensation of Revenue |
1,259.36% | 405.16% | 22.27% | 23.78% | |
Graham Net Nets |
2.02 | 2.22 | 2.64 | 4.72 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(246.46%) | (275.34%) | (292.35%) | (381.30%) | |
Free Cash Flow Yield |
(136.78%) | (116.50%) | (107.33%) | (301.29%) | |
Revenue per Share |
0.01 | 0.01 | 0.01 | 0.03 | |
Operating CF per Share |
(0.73) | (1.08) | (1.24) | (3.06) | |
Capex per Share |
(0.03) | (0.02) | (0.02) | (0.08) | |
Free Cash Flow per Share |
(0.75) | (1.10) | (1.26) | (3.14) | |
Cash per Share |
5.11 | 6.62 | 8.93 | 22.63 | |
Shareholders Equity per Share |
5.33 | 6.91 | 9.23 | 24.13 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.33 | 6.91 | 9.23 | 24.13 | |
Free Cash Flow |
(2.09) | (2.70) | (2.69) | (1.67) | |
Working Capital |
13.55 | 15.76 | 18.39 | 11.56 | |
Capital Expenditures |
(0.07) | (0.04) | (0.05) | (0.04) | |
Net Current Asset Value |
13.55 | 15.76 | 18.39 | 11.56 | |
EV/EBIT |
0.68 | 0.92 | 1.38 | 1.33 | |
Capex to Sales |
2.16 | 1.71 | 2.34 | 2.24 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.03 | 0.02 | 0.03 | 0.02 | |
Average Payables |
0.26 | 0.49 | 0.55 | 0.43 | |
Average Assets |
14.52 | 16.40 | 18.56 | 7.90 | |
Average Common Equity |
13.65 | 15.60 | 17.72 | 6.90 |
Columns are period end dates · fundamentals updated 5 Nov 2026